Walleye Trading’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Walleye Trading’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-23,764	Closed	-$109K	–	4822
2019 Q4	$109K	Buy	23,764 +7,945	+50%	+$31.5K	﹤0.01%	3522
2019 Q3	$61K	Sell	15,819 -36,183	-70%	-$199K	﹤0.01%	3502
2019 Q2	$314K	Buy	+52,002	New	+$497K	﹤0.01%	2574
2019 Q1	–	Sell	-58,340	Closed	-$543K	–	5004
2018 Q4	$543K	Buy	58,340 +40,713	+231%	+$484K	﹤0.01%	2404
2018 Q3	$245K	Buy	17,627 +15,225	+634%	+$226K	﹤0.01%	3599
2018 Q2	$38K	Sell	2,402 -4,174	-63%	-$72.8K	﹤0.01%	4305
2018 Q1	$113K	Buy	+6,576	New	+$128K	﹤0.01%	3851
2017 Q2	–	Sell	-12,200	Closed	-$441	–	5149
2017 Q1	$441	Buy	+12,200	New	+$538K	﹤0.01%	2342
2015 Q3	–	Sell	-300	Closed	-$7K	–	5702
2015 Q2	$7K	Buy	+300	New	+$6.68K	﹤0.01%	4424

Other funds holding FPRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Walleye Trading's FPRX Position: Q1 2020 in Review

Walleye Trading sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2020, closing a stake of 23,764 shares — an estimated $109K sold.

Walleye Trading first reported a position in FPRX in Q2 2015 and held it in 9 quarters. The position peaked at $543K in Q4 2018. 87 funds tracked by Wall St. Rank hold FPRX as of Q1 2020.

Walleye Trading reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
Walleye Trading sold 23,764 Five Prime Therapeutics, Inc. shares in Q1 2020, an estimated $109K.
Walleye Trading first reported a position in Five Prime Therapeutics, Inc. in Q2 2015 and held it in 9 quarters.
Walleye Trading's Five Prime Therapeutics, Inc. position peaked at $543K in Q4 2018.
87 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2020.

Based on Walleye Trading's 13F filing for Q1 2020, filed 15 May 2020.